Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
Program: Scientific Workshops
Session: Opening Remarks
Program: Scientific Workshops
Session: Opening Remarks
Friday, December 6, 2024, 2:00 PM-2:05 PM
Disclosures: Borate: Daiichi Sankyo: Consultancy; Vincerx Pharma: Membership on an entity's Board of Directors or advisory committees; Beigene: Membership on an entity's Board of Directors or advisory committees; Abbvie: Consultancy; BMS: Consultancy; Incyte: Consultancy; Sumitomo: Consultancy; Rigel: Consultancy; Astellas: Consultancy; Takeda: Other: IDMC; Novartis: Consultancy.
See more of: Opening Remarks
See more of: Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
See more of: Scientific Workshops
See more of: Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
See more of: Scientific Workshops
Previous Presentation
|
Next Presentation >>